Location of Repository

Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation

By Laura Astolfi, Sara Ghiselli, Valeria Guaran, Milvia Chicca, Edi Simoni, Elena Olivetto, Giorgio Lelli and Alessandro Martini


Cisplatin is the most common antineoplastic drug used for the therapy of solid tumours. To date, researchers have focused on the dosage to be administered for each specific tumour, mainly considering the local adverse effects. The aim of this study was to correlate the severity of the adverse effects with: i) the dosage of cisplatin; ii) the specific site of the tumour; iii) the association with other drugs; and iv) the symptoms. We analysed data from 123 patients with 11 different tumour classes undergoing therapy from 2007 to 2008 at St. Anna Hospital (Ferrara, Italy), using the Spearman non-parametric correlation index. Even though significant correlations were found among the variables, the overall results showed that the main factor influencing the severity of the adverse effects was the dosage of cisplatin administered

Topics: Adverse effect correlation, Chemotherapy, Cisplatin toxicity, Solid tumours, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Cisplatin, Dose-Response Relationship, Drug, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Male, Middle Aged, Neoplasms, Retrospective Studies, Cancer Research, Oncology
Year: 2013
DOI identifier: 10.3892/or.2013.2279
OAI identifier: oai:iris.unife.it:11392/2335706
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://hdl.handle.net/11392/23... (external link)
  • http://www.spandidos-publicati... (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.